General Information of the Compound
| Compound ID |
CP0098948
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
Impulsin
Show/Hide
|
||||||||||||||||||
| Synonyms |
544-31-0
Anandamide (16:0)
Guanfacine extended release
HEXADECANAMIDE, N-(2-HYDROXYETHYL)-
Hydroxyethylpalmitamide
Impulsin
Loramine P 256
Monoethanolamine palmitic acid amide
N-(2-Hydroxyethyl)hexadecanamide
N-(2-Hydroxyethyl)palmitamide
N-palmitoylethanolamine
NSC 23320
Palmidrol
Palmidrol [INN]
Palmidrolum
Palmidrolum [INN-Latin]
Palmitamide MEA
Palmitic acid monoethanolamide
Palmitinsaeure-beta-hydroxyethylamid
Palmitoyl ethanolamide
Palmitoyl-EA
Palmitoylethanolamide
UNII-6R8T1UDM3V
hexadecanoyl ethanolamide
palmitylethanolamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H37NO2
|
||||||||||||||||||
| Molecular Weight |
299.499
|
||||||||||||||||||
| Canonical SMILES |
CCCCCCCCCCCCCCCC(=O)NCCO
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)19-16-17-20/h20H,2-17H2,1H3,(H,19,21)
Show/Hide
|
||||||||||||||||||
| InChIKey |
HXYVTAGFYLMHSO-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
544-31-0
71060-58-7
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01298, Cannabinoid receptor 1
Protein ID: PT00834, Cannabinoid receptor 2
Protein ID: PT06109, Geminin
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Protein ID: PT06137, Transient receptor potential cation channel subfamily V member 2
Clinical Information about the Compound
Drug 1 ( Guanfacine extended release )
| Drug Name | Guanfacine extended release | ||
|---|---|---|---|
| Company | Shire | ||
| Indication | |||
| Target(s) | |||